Oaktree Acquisition Corp. II

Oaktree Acquisition Corp. II

OACC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$221.89M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Oaktree Acquisition Corp. IIOaktree Acquisition Corp. II58.4--45%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$221.89 Million
Enterprise Value$220.66 Million
Earnings per Share$0.3
Beta-0.04
Outstanding Shares19,199,029

Return

Return on Equity-45.06%ROE
Return on Assets2.08%
Return on Invested Capital-1.64%

Valuation & Multiples

P/E Ratio58.42P/E Ratio
PEG-47.5PEG
Price to Sales-Price to Sales
Price to Book Ratio1.07Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-65.77
Enterprise Value to Net Income50
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 13, 2026
EPS
-$0.02
Reported
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %22.63%▼ 65.69%
Total Invested$46.78M▼ 74.22%
Investors Holding20▼ 31.00%

About Oaktree Acquisition Corp. II

3 employees
CEO: Zaid Pardesi

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or m...